Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

arily due to lower sales to large chains relative to the prior year quarter.

For the full year 2012, Anda Distribution segment net revenues increased 27 percent to $986.4 million, compared to $776.2 million in 2011. This increase was primarily due to new product launches.

Other Operating ExpensesConsolidated GAAP general and administrative expenses were $228.6 million in the fourth quarter 2012, an increase of $125.4 million from the fourth quarter 2011 due to the inclusion of legacy Actavis including certain acquisition, integration and restructuring charges. The current year period was also impacted by charges associated with a product liability settlement. 

Amortization expense for the fourth quarter 2012 was $148.2 million, compared to $151.3 million in fourth quarter 2011.

For the full year 2012, consolidated GAAP general and administrative expenses were $624.9 million, compared to $353.1 million in the prior year period, an increase of $271.8 million.  The increase was due to the acquisition of Ascent and the Actavis Group in January 2012 and November 2012, respectively, including costs associated with the acquisition and integration of these businesses.  Litigation settlements also contributed to the year over year increase.

Amortization expense for the full year 2012 was $481.1 million, compared to $354.3 million in full year 2011, primarily due to atorvastatin and levalbuterol product rights, and amortization of product rights and other intangible assets acquired in the Actavis Group, Specifar, and Ascent acquisitions.

2013 Financial Outlook Actavis' estimates are based on actual results for 2012 and management's current belief about prescription trends, pricing levels, inventory levels and the anticipated timing of future product launches and events. 

Actavis estimates total net revenue for 2013 of approximately $8.1 billion.

  • Total Actavis Pharma segment revenue of between
    '/>"/>

  • SOURCE Actavis, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Watson to Acquire Actavis Group for EUR4.25 Billion
    2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
    3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
    4. Watson and Actavis Receive FTC Second Request
    5. Watson Announces New Name -- Actavis -- for Global Operations
    6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
    7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
    8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
    9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
    10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
    11. Aethlon Medical Note: Fiscal Year Revenue Guidance
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/1/2015)...  BioPharmX Corporation (NYSE MKT: BPMX) today announced the ... 3,636,364 shares of its common stock at a price ... granted the underwriters a 30-day option to purchase up ... public offering price. In addition, Korea Investment ... agreed to purchase 1,081,081 shares of common stock from ...
    (Date:7/1/2015)... SAN FRANCISCO , July 1, 2015 ... health market) is expected to reach USD 49,119.2 million ... View Research, Inc. Monitoring services is expected to remain ... revenue of USD 1,227.5 million in 2012, and an ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , ...
    (Date:7/1/2015)... , July 1, 2015 ... its Executive Board. Mr. Gert Weber has ... Invest AG as Chief Executive Officer (CEO) ... July 1 st , 2015. Mr. Weber brings more ... technological industries and has filled various executive management positions, ...
    Breaking Medicine Technology:BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 2mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 5Haselmeier Group Announces the Extension and Reorganization of its Executive Board 2
    ... 2011 /PRNewswire/ -- PRA, a leading Clinical ... Romania to further strengthen our coverage of the Balkan ... projects in the neighboring Republic of Moldova. ... in Romania, the PRA staff has steadily increased and ...
    ... Aug. 22, 2011 Reportlinker.com announces ... is available in its catalogue: ... Assessments of Leading Suppliers ... This report provides diagnostic imaging industry ...
    Cached Medicine Technology:PRA Opens Office in Romania 2Global MRI Market: Strategic Assessments of Leading Suppliers 2Global MRI Market: Strategic Assessments of Leading Suppliers 3Global MRI Market: Strategic Assessments of Leading Suppliers 4Global MRI Market: Strategic Assessments of Leading Suppliers 5
    (Date:7/1/2015)... ... July 01, 2015 , ... There is nothing ... have been arguing over laws governing sexuality since the first Pilgrims landed at ... historical comparative biography by Cindy Safronoff reveals. Crossing Swords: Mary Baker Eddy vs. ...
    (Date:7/1/2015)... ... July 01, 2015 , ... SuiteRx, innovative ... combo, and compounding pharmacy operations, announces the most recent positioning of SuiteRx CEO, ... RBC event at the Venetian Las Vegas, Nevada. During this event, ...
    (Date:7/1/2015)... PA (PRWEB) , ... July 01, 2015 , ... ... purist natural forms, such as organically raised chickens and eggs. Eating organic foods ... backyard chickens is cleaner and more environmentally friendly than production chicken farming. Choosing ...
    (Date:7/1/2015)... ... July 01, 2015 , ... Dr. Surya Challa of Chesapeake Vein ... WAVY-TV’s The Hampton Roads Show to discuss non-invasive CoolSculpting . On the show, ... short. , CoolSculpting fat reduction utilizes Cryolipolysis to literally freeze stubborn, unwanted fat ...
    (Date:7/1/2015)... ... July 01, 2015 , ... Renowned rhinoplasty surgeon ... for the 2016 Dallas Rhinoplasty Symposium . Set for March 6th - 8th, ... to take participants from the basic training and fundamentals of nasal surgery through the ...
    Breaking Medicine News(10 mins):Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 2Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 4Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 3Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3
    ... for ... Secure Remote Access, ... non-profit hospital system, has chosen PowerTerm WebConnect,Ericom Software,s alternative to ... with secure, on-demand remote access to medical,applications and confidential patient ...
    ... York, N.Y. (Sept. 25, 2007) The majority of breast ... according to new survey results released today. However, the ... take to lessen the likelihood of recurrence is surprisingly ... AstraZeneca and conducted by Harris Interactive, consisted of interviews ...
    ... and Secure Data, Replication for United Mine Workers ... PRAIRIE, Minn., Sept. 25 Xiotech Corporation today,announced ... Health and,Retirement Funds has activated Xiotech(R) TimeScale(TM) Replication,Services ... recovery plan. The,hosted service is protecting the health ...
    ... YORK, Sept. 25 MS sufferers, who have found ... diet that targets,five food triggers. Sugar and saturated fats ... food sensitivities, along with,other simple dietary changes, the MS ... with MS. "By not activating the immune system, ...
    ... new song has helped scientists open a new avenue of ... there is currently no cure or even a treatment to ... in the Journal of Clinical Investigation, scientists at the University ... someday be used to treat the disease. The team used ...
    ... in the Wadden Sea so you have to search for it. ... the best place to go? Initially the food rich spots always ... other animals of course and that gives rise to food competition. ... the prey caught. , Takeaway meal , Experiments revealed ...
    Cached Medicine News:Health News:Ericom Provides Significant Cost-Savings for Major New York City Healthcare Organization 2Health News:Breast cancer survivors optimistic, yet lack critical information on reducing recurrence 2Health News:Health and Pension Benefits Provider Turns to Xiotech's TimeScale Replication Services to Protect Critical Data 2Health News:Health and Pension Benefits Provider Turns to Xiotech's TimeScale Replication Services to Protect Critical Data 3Health News:Multiple Sclerosis Patients Find Dietary Treatment More Effective Than Pharmaceutical Regimens 2Health News:Stem cells show promise for treating Huntington's disease 2Health News:Stem cells show promise for treating Huntington's disease 3Health News:Stem cells show promise for treating Huntington's disease 4
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: